Over the past decade, India’s bioeconomy has blossomed—expanding from just USD 10 billion in 2014 to USD 165.7 billion in 2024, now contributing approximately 4.25% to the nation’s GDP. A bold target has been set to scale this sector to USD 300 billion by 2030. The powerhouse performance reflects strength across four key sub-sectors: BioIndustrial (47%), BioPharma (35%), BioAgri (8%), and BioResearch (9%). Notably, India achieved 20% ethanol blending in 2025, five years ahead of schedule, bolstering farmer incomes and cutting foreign exchange reliance. Additionally, India’s role as a global vaccine manufacturing hub is highlighted by Serum Institute capturing 24% of the global vaccine share in 2024. These milestones are anchored in strategic initiatives such as the BioE³ Policy, along with the launch of the BioE³ Youth Challenge and the National Biofoundry Network, rolled out this August to spur innovation and skill development.
Relevant question for policy stakeholders: What policy frameworks and ecosystem investments can ensure that India’s rising bioeconomy is both scientifically robust and equitably distributed, especially in rural and agro-industrial contexts?
Follow the full news here:
https://www.pib.gov.in/PressNoteDetails.aspx?NoteId=155153&ModuleId=3
